[HTML][HTML] The effects of intranasal, inhaled and systemic glucocorticoids on intraocular pressure: a literature review
D Wijnants, I Stalmans, E Vandewalle - Journal of Clinical Medicine, 2022 - mdpi.com
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
[引用][C] The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans, E Vandewalle - Journal of Clinical Medicine …, 2022 - jglobal.jst.go.jp
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A
Literature Review | Article Information | J-GLOBAL Art J-GLOBAL ID:202202268643191979 …
Literature Review | Article Information | J-GLOBAL Art J-GLOBAL ID:202202268643191979 …
[HTML][HTML] The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
[PDF][PDF] The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans… - Intraocular Pressure and …, 2022 - researchgate.net
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans… - Journal of Clinical …, 2022 - search.proquest.com
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
[PDF][PDF] The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review
D Wijnants, I Stalmans, E Vandewalle - Intraocular Pressure and Ocular …, 2022 - mdpi.com
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review.
D Wijnants, I Stalmans… - Journal of Clinical …, 2022 - search.ebscohost.com
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review.
D Wijnants, I Stalmans, E Vandewalle - Journal of Clinical Medicine, 2022 - europepmc.org
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review.
D Wijnants, I Stalmans, E Vandewalle - Journal of Clinical Medicine, 2022 - europepmc.org
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …
one third of the general population and in up to 90% of glaucomatous patients. Whether this …